401 filings
Page 12 of 21
8-K
coj 76r0wws
15 Mar 05
Entry into a Material Definitive Agreement
12:00am
8-K/A
m9s96go3x6ef
18 Feb 05
Results of Operations and Financial Condition
12:00am
POS AM
zgyqmv0816b1kp3lk
7 Feb 05
Prospectus update (post-effective amendment)
12:00am
8-K
rfzfxt6d26g
26 Jan 05
Results of Operations and Financial Condition
12:00am
8-K
p05mjkw15ga9c0nlv3e
26 Jan 05
Other Events
12:00am
8-K
gxkr49rrohequ vb5
25 Jan 05
Other Events
12:00am
8-K
zp38jizh
23 Nov 04
Other Events
12:00am
8-K
5gatjgo hzoipd4gfto
28 Oct 04
Results of Operations and Financial Condition
12:00am
S-8
gcnncptgbeei
6 Aug 04
Registration of securities for employees
12:00am
8-K
3hunt
21 Jul 04
IMCLONE SYSTEMS AND BRISTOL-MYERS SQUIBB ESTABLISH PLAN WITH FDA FOR THE REGULATORY FILING OF ERBITUX™ (Cetuximab) IN HEAD AND NECK CANCER
12:00am
8-K
hfth436bangkmgar
21 Jul 04
Current report
12:00am
8-K
d1wu6
21 Jun 04
Imclone Systems Announces Fda Approval of CMC Supplemental Bla for Its BB36 Manufacturing Facility
12:00am